685 related articles for article (PubMed ID: 31091372)
1. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Diener HC; Sacco RL; Easton JD; Granger CB; Bernstein RA; Uchiyama S; Kreuzer J; Cronin L; Cotton D; Grauer C; Brueckmann M; Chernyatina M; Donnan G; Ferro JM; Grond M; Kallmünzer B; Krupinski J; Lee BC; Lemmens R; Masjuan J; Odinak M; Saver JL; Schellinger PD; Toni D; Toyoda K;
N Engl J Med; 2019 May; 380(20):1906-1917. PubMed ID: 31091372
[TBL] [Abstract][Full Text] [Related]
2. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Hart RG; Sharma M; Mundl H; Kasner SE; Bangdiwala SI; Berkowitz SD; Swaminathan B; Lavados P; Wang Y; Wang Y; Davalos A; Shamalov N; Mikulik R; Cunha L; Lindgren A; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi RJ; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni D; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; Endres M; Muir KW; Bornstein N; Ozturk S; O'Donnell MJ; De Vries Basson MM; Pare G; Pater C; Kirsch B; Sheridan P; Peters G; Weitz JI; Peacock WF; Shoamanesh A; Benavente OR; Joyner C; Themeles E; Connolly SJ;
N Engl J Med; 2018 Jun; 378(23):2191-2201. PubMed ID: 29766772
[TBL] [Abstract][Full Text] [Related]
4. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR
Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
Uchiyama S; Toyoda K; Lee BC; Liou CW; Wong LKS; Grauer C; Brueckmann M; Taniguchi A; Urano Y; Easton JD;
Stroke; 2021 Mar; 52(3):1069-1073. PubMed ID: 33588594
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
[TBL] [Abstract][Full Text] [Related]
8. Dabigatran vs. Aspirin for Secondary Prevention After Embolic Stroke of Undetermined Source - Japanese Subanalysis of the RE-SPECT ESUS Randomized Controlled Trial.
Toyoda K; Uchiyama S; Hagihara Y; Kuwashiro T; Mori T; Kamiyama K; Urano Y; Taniguchi A; Nozaki K; Cronin L; Grauer C; Brueckmann M; Diener HC
Circ J; 2020 Nov; 84(12):2286-2295. PubMed ID: 33132228
[TBL] [Abstract][Full Text] [Related]
9. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
[TBL] [Abstract][Full Text] [Related]
12. Apixaban versus Aspirin for Embolic Stroke of Undetermined Source.
Geisler T; Keller T; Martus P; Poli K; Serna-Higuita LM; Schreieck J; Gawaz M; Tünnerhoff J; Bombach P; Nägele T; Klose U; Aidery P; Groga-Bada P; Kraft A; Hoffmann F; Hobohm C; Naupold K; Niehaus L; Wolf M; Bäzner H; Liman J; Wachter R; Kimmig H; Jung W; Huber R; Feurer R; Lindner A; Althaus K; Bode FJ; Petzold GC; Nguyen TN; Mac Grory B; Schrag M; Purrucker JC; Zuern CS; Ziemann U; Poli S;
NEJM Evid; 2024 Jan; 3(1):EVIDoa2300235. PubMed ID: 38320511
[TBL] [Abstract][Full Text] [Related]
13. High-Sensitivity Cardiac Troponin T for Risk Stratification in Patients With Embolic Stroke of Undetermined Source.
Scheitz JF; Pare G; Pearce LA; Mundl H; Peacock WF; Czlonkowska A; Sharma M; Nolte CH; Shoamanesh A; Berkowitz SD; Krahn T; Endres M;
Stroke; 2020 Aug; 51(8):2386-2394. PubMed ID: 32640945
[TBL] [Abstract][Full Text] [Related]
14. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346
[TBL] [Abstract][Full Text] [Related]
15. Aortic Arch Atherosclerosis in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial.
Ntaios G; Pearce LA; Meseguer E; Endres M; Amarenco P; Ozturk S; Lang W; Bornstein NM; Molina CA; Pagola J; Mundl H; Berkowitz SD; Liu YY; Sen S; Connolly SJ; Hart RG
Stroke; 2019 Nov; 50(11):3184-3190. PubMed ID: 31526123
[TBL] [Abstract][Full Text] [Related]
16. Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial.
Perera KS; Ng KKH; Nayar S; Catanese L; Dyal L; Sharma M; Connolly SJ; Yusuf S; Bosch J; Eikelboom JW; Hart RG
JAMA Neurol; 2020 Jan; 77(1):43-48. PubMed ID: 31524941
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
Del Brutto VJ; Diener HC; Easton JD; Granger CB; Cronin L; Kleine E; Grauer C; Brueckmann M; Toyoda K; Schellinger PD; Lyrer P; Molina CA; Chutinet A; Bladin CF; Estol CJ; Sacco RL
J Am Heart Assoc; 2022 Jun; 11(11):e023545. PubMed ID: 35656979
[TBL] [Abstract][Full Text] [Related]
18. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
[TBL] [Abstract][Full Text] [Related]
19. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
Hart RG; Sharma M; Mundl H; Shoamanesh A; Kasner SE; Berkowitz SD; Pare G; Kirsch B; Pogue J; Pater C; Peters G; Davalos A; Lang W; Wang Y; Wang Y; Cunha L; Eckstein J; Tatlisumak T; Shamalov N; Mikulik R; Lavados P; Hankey GJ; Czlonkowska A; Toni D; Ameriso SF; Gagliardi RJ; Amarenco P; Bereczki D; Uchiyama S; Lindgren A; Endres M; Brouns R; Yoon BW; Ntaios G; Veltkamp R; Muir KW; Ozturk S; Arauz A; Bornstein N; Bryer A; O'Donnell MJ; Weitz J; Peacock F; Themeles E; Connolly SJ
Eur Stroke J; 2016 Sep; 1(3):146-154. PubMed ID: 31008276
[TBL] [Abstract][Full Text] [Related]
20. Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.
Uchiyama S; Toyoda K; Kitagawa K; Okada Y; Ameriso S; Mundl H; Berkowitz S; Yamada T; Liu YY; Hart RG;
Int J Stroke; 2019 Dec; 14(9):915-922. PubMed ID: 31132967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
